GlassScriptPhysician profile
Thomas Mickowski
NPI 1053997999
$3,449.33
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $651 · 2022: $1,092 · 2023: $1,368 · 2024: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,706.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,011.35 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $329.33 | 2021-2024 | Mounjaro, Jardiance |
| Glaxosmithkline, LLC. | $277.51 | 2021-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $264.45 | 2021-2024 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $241.70 | 2022-2023 | |
| Abbvie INC. | $184.67 | 2021-2023 | |
| Vanda Pharmaceuticals INC. | $166.30 | 2022-2023 | Fanapt, Hetlioz |
| Ucb, INC. | $153.08 | 2023-2024 | Nayzilam, Briviact |
| Amgen INC. | $152.18 | 2021-2023 | Repatha, Otezla |
| Teva Pharmaceuticals USA, INC. | $142.33 | 2022-2023 | Austedo Xr, Austedo |
| Bayer Healthcare Pharmaceuticals INC. | $112.84 | 2021-2023 | |
| Daiichi Sankyo INC. | $86.69 | 2021-2023 | Injectafer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.84 | 2021-2024 | Jardiance, Tradjenta |
| Novartis Pharmaceuticals Corporation | $44.61 | 2022-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.00 | 2021-2023 | Xifaxan |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $30.65 | 2023 | Accrufer |
| Xeris Pharmaceuticals, INC. | $26.36 | 2022 | |
| Eisai INC. | $22.02 | 2021 | |
| Janssen Pharmaceuticals, INC | $20.21 | 2023 | Spravato |
| Exact Sciences Corporation | $17.38 | 2024 | Cologuard Collection Kit |
| Biogen, INC. | $15.59 | 2021 | |
| Paratek Pharmaceuticals, INC. | $15.30 | 2022 | |
| Kyowa Kirin, INC. | $14.31 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $12.58 | 2021 | |
| Vbi Vaccine (Delaware) INC. | $11.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Mickowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.